X4 Pharmaceuticals, Inc.
NASDAQ:XFORBiotechnology
Healthcare
$2.96 +1.49%
+$0.06 today
- Market cap
- $302.26M
- Beta
- 0.37
- P/E (TTM)
- -5.2
- EPS (TTM)
- -$0.79
52W Low $1.35High $4.83
Volume 1.12M
Average 0.40M
Private 5-step workspace
Build a XFOR investment thesis
Turn X4 Pharmaceuticals, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.